The Centers for Medicare & Medicaid Services has delayed 2020 private payer data reporting for the Clinical Diagnostic Test Payment System until 2021 for tests that are not advanced diagnostic laboratory tests, as required by recent legislation extending funding for federal programs through fiscal year 2020. Under the legislation, applicable laboratories, including hospital outreach laboratories, that were to report data between Jan. 1 and March 31, 2020, will instead report the data between Jan. 1, 2021, and March 31, 2021. Data reporting then will resume on a three-year cycle beginning in 2024. In addition, CMS may not reduce 2020 payment rates for clinical diagnostic laboratory tests that are not advanced or new tests by more than 10% in 2020 and by more than 15% per year in 2021, 2022 or 2023. Congress also directed the Medicare Payment Advisory Commission to study and report within 18 months on the least burdensome data collection process that would lead to a “representative and statistically valid data sample of private market rates from all laboratory segments,” including hospital outreach laboratories. The study will consider the variability of private market rates and the appropriate statistical methods for estimating representative rates. 
 

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…